bioLytical Laboratories Named as One of BC’s Fastest-Growing Companies for the Fifth Year

bioLytical Laboratories Inc. has been named one of the fastest-growing companies in British Columbia for 2021, our fifth straight year on the list.

bioLytical Laboratories Inc. has once again been named one of the fastest-growing companies in British Columbia, according to recent research conducted by Business in Vancouver (BIV). Each year, BIV researches companies headquartered in British Columbia to determine our province’s fastest-growing companies by revenue growth over the past five years. The annual listing showcases Vancouver’s place as an economic hub across all industries, including Life Sciences and Biotech. 

After a challenging year marked by the ongoing COVID-19 pandemic, we are happy to announce that we have been placed on the list for 2021. We are proud of our team’s efforts to address and overcome the challenges of a changing world, and we are pleased to represent bioLytical and the industry once again this year. We have been named each year since 2017, with this year marking our fifth, and we love that this showcases the growth and fantastic work and commitment of our team here at bioLytical.

As the world continues to evolve towards living with COVID-19, there is a growing awareness and need for innovative and effective solutions for rapid testing, our INSTI platform. With the world’s fastest HIV and HCV tests, our platform offers a powerful tool in helping end epidemics and provides an accurate, easy-to-use, and convenient test. Since last year’s list, we have received Health Canada approval for our INSTI HIV-1/2 Antibody Self Test and received CE Mark for our INSTI HCV Antibody Test and COVID-19 Antibody Test furthering our expansion and growth.

By delivering accurate results in real-time, INSTI® is proud to generate meaningful outcomes for medical professionals, patients, and public health organizations worldwide, and we will continue to be a key partner in tackling some of the world’s most severe healthcare challenges.